Generic Name and Formulations:
Beclomethasone dipropionate 40mcg, 80mcg; per actuation; non-aqueous nasal spray soln.
Indications for QNASL:
Seasonal and perennial allergic rhinitis.
Adults and Children:
<4yrs: not established. 4–11yrs: 1 spray (40mcg) in each nostril once daily; max: 2 sprays per day. ≥12yrs: 2 sprays (80mcg) in each nostril once daily; max: 4 sprays per day.
Avoid in recent nasal septal ulcers, nasal surgery, or nasal trauma until healed. Monitor periodically for possible changes in nasal mucosa or Candida infection with long-term use. Discontinue if nasal erosion/ulceration or Candida infection occur (treat with local therapy). Change in vision, history of increased intraocular pressure, blurred vision, glaucoma, and/or cataracts: monitor closely. Respiratory tract tuberculosis. Untreated infections (eg, fungal, bacterial, viral, ocular herpes simplex). If exposed to measles or chickenpox, consider anti-infective prophylactic therapy. If adrenal insufficiency exists following systemic corticosteroid therapy, replacement with intranasal corticosteroids may exacerbate symptoms of adrenal insufficiency (eg, lassitude, depression). Monitor for hypercorticism and adrenal suppression (if occur discontinue gradually). Monitor for growth suppression in children. Avoid eyes, mouth and face. Pregnancy (Cat.C). Nursing mothers.
Nasal discomfort, epistaxis, headache, pyrexia, upper respiratory tract infection, nasopharyngitis; hypersensitivity reactions (discontinue if occurs).
Aerosol 40mcg—4.9g (60 actuations), 8.7g (120 actuations); 80mcg—8.7g (120 actuations)
Neurology Advisor Articles
- The Consequences of Compensation in Autism
- Fingolimod May Help Prevent Brain Volume Loss in Relapsing-Remitting Multiple Sclerosis
- Novel Therapy May Improve Symptoms in Early Huntington Disease
- Interaction of Alcohol, Smoking on Multiple Sclerosis Severity
- Demoralization Common in Patients With Parkinson Disease
- Multiple Sclerosis Guidelines: AAN's Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy
- Migraine a Common Comorbidity in Individuals With Sarcoidosis
- Cardiovascular Risk Factors and Development of Brain Atrophy in Multiple Sclerosis
- Association Between Multiple Sclerosis Relapses and Vaccinations
- Understanding Impulse Control Disorders in Parkinson Disease: Developments and Treatments